drugset / Trial / NCT00481559
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
Expanded access
Approved for marketing
BTG International Inc.
CTI Clinical Trial and Consulting Services · collab
Summary
This protocol is for the treatment of toxic plasma methotrexate concentrations (\>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucarpidase | Protein / enzyme biologic | 50 iu/kg | Intravenous |